Central African Republic

Reimbursed Care Access

The Central African Republic (CAR) is a party to international drug control conventions and follows a highly restrictive approach to classic psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X, etc.), which are controlled under the UN psychotropic substances framework and have no authorized medical/reimbursed use outside approved research. Ketamine is an established, WHO‑listed anesthetic available in many low‑resource African health systems and therefore used clinically in CAR; however, there is no evidence of a reimbursed, formal national program for psychiatric uses (and no evidence of esketamine reimbursement or marketing authorization in CAR).